Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska Natives

Abstract

(1975 through 2004) and fixed-interval (1995 through 2004) incidence and mortality trends were evaluated by annual percent change using regression analyses (2-sided P < .05). Cancer screening, risk factors, socioeconomic characteristics, incidence data, and stage were compiled for non-Hispanic whites (NHW) and AI/AN across 6 regions of the U.S.We thank Andrew Lake, Rick Firth, Danielle Melbert, and Martin Krapcho of Information Management Services, Inc. for assisting in statistical analyses.We also thank Tom Richards and Mary White, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia for assistance with graphics and their helpful comments on the article. Phyllis A. Wingo was under contract with the Indian Health Service for a portion of her work on this manuscript. This article was originally published online on October 15, 2007, and it is presented here with the following modifications: Dr. Wu's degree appears correctly above, and some data was realigned in the tables to improve the readability of the data being presented. The changes do not affect the core data or the conclusions of the article in any way. The publisher apologizes for this oversight and any confusion that may have ensued. Among women, lung cancer incidence rates no longer were increasing and death rates, although they still were increasing slightly, were increasing at a much slower rate than in the past. Breast cancer incidence rates in women decreased CONCLUSIONS. For all races/ethnicities combined in the U.S., favorable trends in incidence and mortality were noted for lung and colorectal cancer in men and women and for breast cancer in women. For the AI/AN population, lower overall cancer incidence and death rates obscured important variations by geographic regions and less favorable healthcare access and socioeconomic status. T he American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate annually to assess the cancer burden in the U.S. The 1998 report documented the first sustained decline in cancer death rates since the 1930s.1 Subsequent reports updated information on trends in incidence and death rates and featured timely, in-depth analyses of selected topics. 2-9 The American Indian and Alaska Native (AI/AN) cancer experience has not been described well except for a few geographic areas. This 2007 report updates the cancer profile for the U.S. and describes regional patterns of cancer in AI/AN using methods that mitigate the effects of race misclassification. MATERIALS AND METHODSCancer Cases, Cancer Deaths, and Population Estimates U.S. cancer deaths, reported to state vital statistics offices and consolidated through CDC's National Vital Statistics System, 12 were coded using the version of the ICD in use at the time of death. [13][14][15][16] Underlying causes of cancer death were grouped according to the SEER cause of death recode f...

microRNA-320a inhibits tumor invasion by targeting neuropilin�1 and is associated with liver metastasis in colorectal cancer

“…Colorectal cancer (CRC) is the second most common cause of cancer-related death worldwide (1). Approximately 50% of patients diagnosed with CRC die as a result of complications from distant metastases, which occur mainly in the liver.…”

“…The role of miRNAs in the development of metastasis has been demonstrated in several cancer types, including breast cancer, hepatocellular carcinomas, head and neck cancer and brain tumors (17). Most studies involving CRC have analyzed the association between miRNAs and microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer metastasis using both in vitro and mouse models. Most tissuebased experiments derived from CRC patients are only able to identify differential miRNAs using primary tumor tissues versus normal tissue (15).…”

The Changing Incidence of In situ and Invasive Ductal and Lobular Breast Carcinomas: United States, 1999-2004

“…Decreases in mammography use and declines in the use of CHRT have both been postulated as a cause for the decrease in overall breast cancer incidence in 2002 (22,(24)(25)(26)(36)(37)(38). However, unlike ductal carcinoma, lobular breast cancer is not detected primarily through mammography.…”

Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

“…2 Recent trends in CRC incidence and mortality reveal declining rates, which have been attributed to reduced exposure to risk factors, screening's effect on early detection and prevention through polypectomy, and improved treatment. 3 However, in the near term, even greater incidence and mortality reductions could be achieved if a greater proportion of adults received regular screening. Although prospective randomized trials and observational studies have demonstrated mortality reductions associated with early detection of invasive disease, as well as removal of adenomatous polyps, 4-7 a majority of US adults are not receiving regular ageand risk-appropriate screening or have never been screened at all.…”